deoxypyridinoline has been researched along with Sclerosis, Systemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atteritano, M; Bagnato, G; Miceli, G; Morgante, S; Sangari, D; Sorbara, S; Visalli, E | 1 |
| Franzblau, C; Korn, JH; Lally, EV; Miller, LC; North, H; Snider, GL; Stone, PJ; Strongwater, S; Tucker, LB | 1 |
2 other study(ies) available for deoxypyridinoline and Sclerosis, Systemic
| Article | Year |
|---|---|
Bone mineral density, bone turnover markers and fractures in patients with systemic sclerosis: a case control study.
Topics: Absorptiometry, Photon; Amino Acids; Biomarkers; Bone and Bones; Bone Density; Calcifediol; Case-Control Studies; Female; Femur; Femur Neck; Fractures, Bone; Humans; Logistic Models; Middle Aged; Multivariate Analysis; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone; Scleroderma, Systemic | 2013 |
Cross-linked elastin and collagen degradation products in the urine of patients with scleroderma.
Topics: Adult; Aged; Amino Acids; Collagen; Desmosine; Elastin; Female; Humans; Isodesmosine; Male; Middle Aged; Reference Values; Scleroderma, Systemic | 1995 |